Henry Ji
Onye isi oche, Onye isi ala na onye isi
- Ahụmịhe afọ 25+ na biotechnology na ụlọ ọrụ sayensị ndụ
- Dr. Ji kwadoro Sorrento wee jee ozi dị ka onye nduzi kemgbe 2006, CEO na President kemgbe 2012, na onyeisi oche kemgbe 2017.
- N'oge ọrụ ya na Sorrento, ọ rụpụtala ma duzie uto dị egwu nke Sorrento site na nnweta na njikọta gụnyere Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Description Health, na Sopharmaceutical Systems
- jere ozi dị ka onye isi Sayensị Sayensị nke Sorrento site na 2008 ruo 2012 yana dị ka onye isi nwa oge ya site na 2011 ruo 2012
- Tupu Sorrento, ọ nọrọ n'ọkwa onye isi na CombiMatrix, Stratagene ma rụkwaa Stratagene Genomics, onye enyemaka nke Stratagene, wee jee ozi dị ka Onye isi ala & onye isi na onye isi oche nke Board.
- BS na Ph.D.
Mechie >
Mike Royal
Medical Officer
- Dr. Royal bụ onye isi ụlọ ọgwụ nwere afọ 20 nke mmepe ụlọ ọgwụ na ihe gbasara ahụike. N'oge na-adịbeghị anya, ọ bụ onye isi nlekọta ahụike nke Suzhou Connect Biopharmaceuticals na, tupu nke ahụ, Concentric Analgesics. Ọ sonyeere Sorrento ebe ọ bụbu EVP, Clinical Development na Regulatory Affairs na 2016
- Ọ bụbu ọrụ maka ma ọ bụ nyere aka n'ọtụtụ NDA na-aga nke ọma, gụnyere NCE, 505(b)(2)s na ANDA.
- Dr. Royal bụ bọọdụ gbaara ama na ọgwụ ime, ọgwụ mgbu, anesthesiology nwere ntozu ndị ọzọ na njikwa mgbu, ọgwụ riri ahụ na ọgwụ iwu.
- Ọ bụbu onye enyemaka prọfesọ nke ọgwụ na Uniformed Services University of Health Sciences, Assistant Prọfesọ nke Anesthesiology/Critical Care Medicine na Mahadum Pittsburgh Medical Center, na Prọfesọ Adjunct na Mahadum Oklahoma na Mahadum California San Diego.
- O bipụtala nke ukwuu yana ihe karịrị isiakwụkwọ akwụkwọ 190, akụkọ ndị ọgbọ nyochara na akwụkwọ akụkọ / akwụkwọ mmado; bụrụkwa onye a kpọrọ òkù na nzukọ mba na mba ụwa
- BS, MD, JD, MBA
Mechie >
Elizabeth Czerepak
Onye isi oche onye isi oche, onye isi ego, onye isi azụmahịa
- Afọ 35+ nke ahụmahụ ego na arụmọrụ na biotech na ọgwụ ọgwụ
- Nwada Czerepak nọrọ afọ 18 na nnukwu Pharma na afọ 11 dị ka CFO nke teknụzụ biotech dị iche iche, ebe o duziri ego, mmekorita na mbọ M&A. Malitere ọrụ ya na Merck & Co., rụrụ ọrụ dị mkpa na Roche's $5.4B nweta Syntex, wee duzie mbọ mmekọ maka Humira® nke mechiri na BASF Pharma's $6.8B ire Abbott.
- Ruo afọ itoolu dị ka onye isi nchịkwa na JP Morgan na Bear Stearns, ọ na-etolite onye mmekọ n'ozuzu nke $212M venture Fund, ebe ọ na-eduzi itinye ego na 13 biotechs, na-eje ozi na bọọdụ na ịkwado ọpụpụ site na IPO na inweta. Usoro nke 7 na usoro 63 FINRA (NASD) onye nnọchite anya edebanyere aha site na 2001 ruo 2008.
- Onye otu bọọdụ nwere ahụmahụ (gụnyere Sorrento na Scilex) na onye isi oche nyocha, na-enweta Asambodo Onye isi ụlọ ọrụ sitere na Harvard Business School na 2020.
- BA na MBA
Mechie >
Mark R. Brunswick
Senior Vice President Regulatory Affairs
- Dr. Brunswick nwere n'elu 35 afọ nke agadi ọkwá na Regulated Industry gụnyere ihe karịrị 9 afọ na US FDA, Center for Biologics, Division of Monoclonal Antibodies.
- Tupu ịbanye na Sorrento, Dr. Brunswick bụ onye isi nke Regulatory Affairs and Quality na Sophiris Bio, ụlọ ọrụ na-emepụta ọgwụ maka hyperplasia prostate na-adịghị mma na ọrịa cancer prostate. Tupu mgbe ahụ ọ bụ onye isi nke Regulatory Affairs na Arena Pharmaceuticals ọkachamara na ọgwụgwọ ndị a na-eduzi na G Protein receptors.
- Dr. Brunswick duru ndị na-ahụ maka nhazi na Elan Pharmaceuticals na-etinye uche na ọrịa Alzheimer na ihe mgbu mgbu, ziconotide.
- BS na Ph.D.
Mechie >
Xiao Xu
Onye isi ala ACEA
- Dr. Xu nwere ihe karịrị 20 afọ ahụmahụ dị ka onye isi na biotech industries. Dr. Xu bụ onye nchoputa, onyeisi oche na CEO nke ACEA Biosciences (nke Agilent nwetara na 2018) na ACEA Therapeutics (nwetara site na Sorrento Therapeutics na 2021). Ọ na-esonye Sorrento Therapeutics mgbe enwetara ya, ma na-aga n'ihu na-arụ ọrụ dị ka Onye isi oche nke ACEA, enyemaka nke Sorrento Therapeutics.
- Ọ na-ahụ maka ma na-ahụ maka ACEA mmepe pipeline ọgwụ ọhụrụ, ọmụmụ ụlọ ọgwụ, na ụlọ nrụpụta cGMP.
- Ọ bụ onye na-emepụta ihe ọhụrụ akara teknụzụ nyocha mkpụrụ ndụ na-akwụghị ụgwọ ma na-ahụ maka teknụzụ/mmepe ngwaahịa na mmekorita azụmahịa na Roche Diagnosis, azụmahịa zuru ụwa ọnụ nke teknụzụ na ngwaahịa ACEA, yana $250 nde Agilent nweta ACEA Biosciences.
- Ọ bụbu onye nyocha na onye nyocha sayensị na Gladstone Institutes, Scripps Research Institute na Centlọ Ọrụ Maka Nchịkwa na Mgbochi Ọrịa US. O nwere ihe karịrị 50 US patent na ngwa ngwa ma bipụtala ihe karịrị 60 akụkọ nyocha na akwụkwọ akụkọ mba ụwa, gụnyere Sayensị, PNAS, Nature Biotechnology, na Chemistry na Biology.
- BS, MS, na MD
Mechie >
Shawn Sahebi
Senior Vice President Commercial Operations
- Dr. Sahebi na-eduzi ọrụ azụmahịa nke Sorrento
- Na-eweta ihe karịrị afọ 30 nke ahụmịhe ọgwụ gụnyere sayensị ahịa na atụmatụ azụmaahịa na Sorrento.
- Tupu ịbanye na Sorrento, ọ nọrọ n'ọkwá dị elu na Novartis, Pfizer, na Lilly na-emepụta nyocha azụmahịa na usoro ịzụ ahịa data na-akpata maka nnukwu ahịa ahịa nke ihe karịrị ngwaahịa 20 na-erute ọkwa blockbuster na mpaghara Cardiovascular, Arthritis, Neuroscience, Diabetes, na Oncology.
- Onye kwere ekwe siri ike na omenala imekọ ihe ọnụ na-emepụta otu mmeri
- Onye isi ala gara aga, Association Science Management Science Association of America
- BA, MBA na Ph.D.
Mechie >
Brian Cooley
Senior osote onye isi ala, Nkwukọrịta ụlọ ọrụ na Lymphatic Drug Development BU
- Ahụmịhe afọ 30+ na biopharmaceutical na ụlọ ọrụ sayensị ndụ
- Mazị Cooley nwere ọkwa dị iche iche ahịa, ire ahịa na azụmaahịa azụmaahịa na ụlọ ọrụ 500 akụ na ụba ma duzie ego n'ịkwalite ma malite mbọ maka ụlọ ọrụ teknụzụ ahụike.
- Tupu ịbanye na Sorrento, Maazị Cooley duziri mgbalị mmalite ngwaahịa ọhụrụ nke ahịa ụwa na ọrụ P&L na Eli Lilly na Company na Genentech na mpaghara ọrịa gụnyere ọrịa shuga, Neurology, Immunology na Rare Disease.
- Na mgbakwunye, ọ eduzila BD dị ịrịba ama, inye ikike, na ntinye aka na mba ụwa na na US Nke a gụnyere ọtụtụ azụmahịa mgbasawanye azụmahịa Europe, Middle East na Africa, na nkwekọrịta mmekorita $ 400MM iji nweta ikikere, ịzụlite na ịzụ ahịa. GLP-1 agonist nke mbụ
- N'oge na-adịbeghị anya, Maazị Cooley bụ CBO maka Ngalaba Azụmahịa Sofusa na Kimberly-Clark wee duru ahịa ire na ntinye nke ọma na mbọ. Sorrento Therapeutics. Ọ na-aga n'ihu na-eduzi nkewa sistemụ nnyefe ọgwụ Lymphatic na Sorrento.
- BS
Mechie >
Bill Farley
Osote onye isi oche mmepe azụmahịa
- Ahụmịhe afọ 30+ na Mmepe Azụmahịa, Ahịa na mbọ na-eduga na nchọpụta ọgwụ, mmepe na mmekorita
- Tupu ịbanye na Sorrento, Maazị Farley ejidewo ọnọdụ onye isi na HitGen, WuXi Apptec, VP nke isi ihe ndekọ ego na-eduga otu òtù BD zuru ụwa ọnụ; ChemDiv, VP nke BD na, na-eduga ọtụtụ mbọ iji mepụta ụlọ ọrụ ọgwụgwọ ọhụrụ na CNS, Oncology na Anti-infectives.
- Mazị Farley jerela ozi dị ka onye na-ahụ maka ndị otu njikwa ọrụ dị iche iche na BOD iji zụlite na ịzụ ahịa ihe dị ka Xencor, Caliper Teknụzụ na Stratagene.
- Ọ wulitela netwọkụ siri ike na ụlọ ọrụ ọgwụ, biotech na obodo Venture Capital. Mazị Farley ekwuwo okwu n'ọtụtụ ọgbakọ ma e bipụtala ya n'ụdị akwụkwọ akụkọ nyocha nke ndị ọgbọ
- BS
Mechie >
Alexis Nahama
Senior osote onye isi oche Neurotherapeutics BU
- Dr. Nahama na-eduga RTX mmemme mmepe ọgwụ ahụike mmadụ na anụmanụ
- Dị ka otu onye ndu otu, Dr. Nahama na-akwado mmepe atụmatụ, na-ahụ maka ọrụ bara uru dị elu, na-eme ka ịga na nkwadebe ahịa, ma na-azụlite mbọ njikọ dị n'èzí.
- Na-anụ ọkụ n'obi na-akwalite ohere ntụgharị asụsụ iji mee ka mmemme mmepe mmadụ dịkwuo ngwa ma na-ebute teknụzụ ndị na-agaghị adị maka anụ ụlọ.
- Tupu ịbanye na Sorrento, ọ nọrọ ihe karịrị afọ 25 na-ejide ọrụ nchịkwa ụwa na-arụ ọrụ na Life Sciences na Biotechnology maka Sanofi, Colgate, Novartis, Merck, VCA Antech na VetStem Biopharma
- DVM nwere ọrụ mbụ lekwasịrị anya na R&D na mpaghara mgbu (nnwale ụlọ ọgwụ maka anụ ụlọ)
Mechie >
10bio na-aga ebe a10: dangler l=5